GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laurus Labs Ltd (BOM:540222) » Definitions » Operating Margin %

Laurus Labs (BOM:540222) Operating Margin % : 9.67% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Laurus Labs Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Laurus Labs's Operating Income for the three months ended in Mar. 2024 was ₹1,392 Mil. Laurus Labs's Revenue for the three months ended in Mar. 2024 was ₹14,397 Mil. Therefore, Laurus Labs's Operating Margin % for the quarter that ended in Mar. 2024 was 9.67%.

Good Sign:

Laurus Labs Ltd operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for Laurus Labs's Operating Margin % or its related term are showing as below:

BOM:540222' s Operating Margin % Range Over the Past 10 Years
Min: 7.79   Med: 15.3   Max: 28.51
Current: 7.8


BOM:540222's Operating Margin % is ranked better than
54.72% of 1018 companies
in the Drug Manufacturers industry
Industry Median: 6.075 vs BOM:540222: 7.80

Laurus Labs's 5-Year Average Operating Margin % Growth Rate was 0.30% per year.

Laurus Labs's Operating Income for the three months ended in Mar. 2024 was ₹1,392 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 was ₹3,929 Mil.


Laurus Labs Operating Margin % Historical Data

The historical data trend for Laurus Labs's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laurus Labs Operating Margin % Chart

Laurus Labs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.75 28.51 23.99 20.99 7.79

Laurus Labs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.38 6.45 7.72 6.95 9.67

Competitive Comparison of Laurus Labs's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Laurus Labs's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laurus Labs's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laurus Labs's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Laurus Labs's Operating Margin % falls into.



Laurus Labs Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Laurus Labs's Operating Margin % for the fiscal year that ended in Mar. 2024 is calculated as

Operating Margin %=Operating Income (A: Mar. 2024 ) / Revenue (A: Mar. 2024 )
=3929.2 / 50408.3
=7.79 %

Laurus Labs's Operating Margin % for the quarter that ended in Mar. 2024 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=1392.4 / 14396.7
=9.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Laurus Labs  (BOM:540222) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Laurus Labs Operating Margin % Related Terms

Thank you for viewing the detailed overview of Laurus Labs's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Laurus Labs (BOM:540222) Business Description

Traded in Other Exchanges
Address
Road No. 7, Banjara Hills, 2nd Floor, Serene Chambers, Hyderabad, TG, IND, 500034
Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceuticals ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services and others.

Laurus Labs (BOM:540222) Headlines

No Headlines